Center Star Asset Management, LLC Amgen Inc Transaction History

Center Star Asset Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 23, 2021	SELL	$221.91 - $258.6 $241,438 - $281,356	-1,088 Reduced 93.31%	78 $19,000
Q4 2020 Jan 27, 2021	SELL	$216.38 - $257.67 $121,605 - $144,810	-562 Reduced 32.52%	1,166 $265,000
Q3 2020 Oct 26, 2020	BUY	$234.65 - $260.95 $138,443 - $153,960	590 Added 51.85%	1,728 $429,000
Q2 2020 Aug 05, 2020	BUY	$197.81 - $242.74 $145,390 - $178,413	735 Added 182.38%	1,138 $264,000
Q4 2019 Jan 14, 2020	BUY	$189.21 - $243.2 $76,251 - $98,009	403 New	403 $97,000
Q2 2019 Aug 02, 2019	SELL	$166.7 - $195.41 $192,371 - $225,503	-1,154 Closed	0 $0
Q1 2019 Apr 29, 2019	BUY	$180.87 - $203.88 $202,574 - $228,345	1,120 Added 3294.12%	1,154 $217,000
Q4 2018 Jan 16, 2019	SELL	$178.4 - $208.25 $1.15 Million - $1.34 Million	-6,426 Reduced 99.47%	34 $6,000
Q2 2018 Jul 09, 2018	SELL	$166.05 - $186.51 $775,785 - $871,374	-4,672 Reduced 41.97%	6,460 $1.18 Million
Q1 2018 May 01, 2018	BUY	$169.43 - $198.0 $1.89 Million - $2.2 Million	11,132 New	11,132 $1.9 Million

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Center Star Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Center Star Asset Management, LLC with notifications on news.